Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

social media monitoring

ATS Social Media Report

Trending at ATS 2025: Social Media Insights from X

📊 ATS 2025 Social Media Insights | Download the Full Report! 📥 How is social…

ASGCT 2025

Trending at ASGCT 2025 : Social Media Insights from X

📊 ASGCT 2025 Social Media Insights | Download the Full Report! 📥 How…

ASCO 2025 Social Media Report

Trending at ASCO 2025 : Social Media Insights from X

📊 ASCO 2025 Social Media Insights | Download the Full Report! 📥 👉…

LucidQuest Case Study Oncology

How we helped two pharma companies assess their own and their competitors' social media during ESMO 2023 and ASCO 2023.

The Challenge: How to maximize the benefits of social media monitoring during…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Coverage
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

Tags

AAV vector AMT-130 Apple Watch Hypertension Areteia Therapeutics ARIA-H arthritis therapy Ascletis ATM-negative mCRC Avidity Biosciences BIMZELX cadonilimab CARTITUDE-4 CIRM clesrovimab DENALI DESTINY-Breast09 deupirfenidone EMD Serono Fay dietitians FXa DOAC GRADE Hemlibra Lyme vaccine MDD miR-22 NCCN NHS England AI imaging NHS fetal anomaly AI Ocugen OGT OSENVELT Overall survival Ozuriftamab vedotin pediatric T2D pembrolizumab Protalix Ruxolitinib Cream SAVR SCAI Door to Lactate Clearance Servier Skyhawk Therapeutics Smoking splicing modulator UK Biobank Viridian Therapeutics

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

TAGS

AAV vector AMT-130 Apple Watch Hypertension Areteia Therapeutics ARIA-H arthritis therapy Ascletis ATM-negative mCRC Avidity Biosciences BIMZELX cadonilimab CARTITUDE-4 CIRM clesrovimab DENALI DESTINY-Breast09 deupirfenidone EMD Serono Fay dietitians FXa DOAC GRADE Hemlibra Lyme vaccine MDD miR-22 NCCN NHS England AI imaging NHS fetal anomaly AI Ocugen OGT OSENVELT Overall survival Ozuriftamab vedotin pediatric T2D pembrolizumab Protalix Ruxolitinib Cream SAVR SCAI Door to Lactate Clearance Servier Skyhawk Therapeutics Smoking splicing modulator UK Biobank Viridian Therapeutics

Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy